Lidocaine Hydrochloride

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

Supply fragility

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

• related presentation in shortage+15
• Class I/II recall in past 12 months+15
• price down 34% year over year+8
• sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

OAI inspection at a producing facility (24 months) · sole-source market · 2 Class I/II recall(s) in 12 months

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →